Original ArticleIndian Journal of Pharmaceutical Education and ResearchVol. 56 | Issue 4 | 2022 | pp. 1226–1231Open access
The Prevalence of Anemia and Hematological Findings in COVID-19 Patients in Saudi Arabia
- 1*,
- 1,
- 1,
- 1,
- 1,
- 1,
- 1,
- 1,
- 1,
- 2,
- 2,
- 5,
- 3,
- 1,
- 4
- 1 Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, SAUDI ARABIA.
- 2 Department of Chemistry, College of Sciences, Taif University, Taif, SAUDI ARABIA.
- 3 Department of Internal Medicine, Section of Infectious Diseases, Prince Mohammed Bin Abdulaziz Hospital, Riyadh, SAUDI ARABIA.
- 4 Department of Medical Laboratory Technology, College of Applied Medical Sciences, Jazan University, Jazan, SAUDI ARABIA.
- 5 Department of Clinical Laboratory, Prince Mohammed Bin Abdulaziz Hospital, Riyadh, SAUDI ARABIA.
Published in Indian Journal of Pharmaceutical Education and Research
Correspondence: Mazen Almehmadi
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, SAUDI ARABIA.
Email: tdr.mazen.ma@gmail.com
Copyright: © 2022 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2022
- Received:
- Nov 17, 2021
- Accepted:
- Jul 7, 2022
- DOI:
- 10.5530/ijper.56.4.204
How to cite
Almehmadi, M., Salih, M., Al-hazmi, A., Alenazi, M., Abdulaziz, O., Almalki, F., Shafie, A., Alsiwiehri, N., Allahyani, M., Althibity, N., Alosimi, E., Turjoman, A., Rebh, F., Aljuaid, A., & Halawi, M. (2022). The Prevalence of Anemia and Hematological Findings in COVID-19 Patients in Saudi Arabia. Indian Journal of Pharmaceutical Education and Research, 56(4), 1226–1231. https://doi.org/10.5530/ijper.56.4.204
Abstract
Objectives: The aim of this study was to estimate the prevalence of anemia among COVID-19 patients in Saudi Arabia and evaluate their hematological parameters. Materials and Methods: A descriptive, cross-sectional, hospital-based study was conducted between February 2021 to March 2021, data collection covered the period between September 2020 to March 2021. All the patients were hospitalized for confirmed COVID-19. Results: A total of 6048 COVID-19 patients included in our study, 2358 (48.9%) were anemic, 3666 (60.61%) were normal HGB level, and only 24 (0.49%) were having polycythemia. Hemoglobin level ranged from 5 g/dL to 18 g/dL with a median (interquartile range) of 11.8 g/dL (8.9 to 13.1) g/dL. The median for male (interquartile range) was for anemic patient’s 9.8 g/dL (8.5 to 11.4) g/dL, normal 14 g/dL (13.5 to 14.8) g/dL, and polycythemia 17.4 g/dL (17.2 to 17.7) g/dL. The median for female (interquartile range) was for anemic patient’s 9.1 g/dL (8.2 to 10.2) g/dL, normal 13.5 g/ dL (12.5 to 14.5) g/dL, and polycythemia 17 g/dL (16.82 to 17.2) g/dL. Hematological parameters detected are indicative of severe complications in anemic patients compared to non-anemic patients. Conclusion: Our findings were consistent with other studies that reported poor outcomes of anemia in COVID-19 patients.
Keywords
Subject
Article metadata
| Title | The Prevalence of Anemia and Hematological Findings in COVID-19 Patients in Saudi Arabia |
|---|---|
| Authors | Mazen Almehmadi; Magdi Salih; Ayman Al-hazmi; Muhannad Alenazi; Osama Abdulaziz; Faisal Almalki; Alaa Shafie; Naif Alsiwiehri; Mamdouh Allahyani; Njoud Althibity; Ebtisam Alosimi; Abdullah Turjoman; Fatimah Rebh; Abdulelah Aljuaid; Mustafa Halawi |
| Affiliations | Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, SAUDI ARABIA.; Department of Chemistry, College of Sciences, Taif University, Taif, SAUDI ARABIA.; Department of Internal Medicine, Section of Infectious Diseases, Prince Mohammed Bin Abdulaziz Hospital, Riyadh, SAUDI ARABIA.; Department of Medical Laboratory Technology, College of Applied Medical Sciences, Jazan University, Jazan, SAUDI ARABIA.; Department of Clinical Laboratory, Prince Mohammed Bin Abdulaziz Hospital, Riyadh, SAUDI ARABIA. |
| Corresponding author | tdr.mazen.ma@gmail.com |
| Journal | Indian Journal of Pharmaceutical Education and Research |
| Volume / Issue | Vol. 56, Issue 4 (2022) |
Also in this issue
- Professional Master of Pharmacy Education in Chinapp. 907–916
- Human Follicular Fluid, Clinical Use of Proteomics Analysis in Identification of Infertilitypp. 917–923
- Recent Advances and Appropriate Use of Niosomes for the Treatment of Skin Cancerpp. 924–937
- Animal Models Alternatives: Desideratum during COVID-19 Pandemicpp. 938–949
- Indian Pharmaceutical Product Protection by Utilizing Intellectual Property Rightspp. 950–958